The pharmaceutical sector is struggling with prolonged and prohibitively expensive drug discovery and development processes. And they seem to only worsen over time. Deloitte studied 20 top global pharma... Read more »
The pharma industry is struggling with prolonged and extremely expensive drug discovery and development. It takes on average 10 to 15 years to produce a drug, and, according to... Read more »
At Gramener, our Subject Matter Experts (SMEs) share their perspectives on the latest innovations in the data & AI world. In this article, Santosh Shevade, our Principal Data Consultant... Read more »
Article summary: The pharma sector has access to a lot of data: electronic health records, genomic information, real-world evidence, and more. All this data combined can be referred to... Read more »
Take a look at these statistics: Artificial intelligence can reduce drug discovery costs by up to 70% according to a recent study by Insider Intelligence AI can save pharma... Read more »
In the US, the Food and Drug Administration (FDA) acts as a primary entity setting standards for compliance in pharma. In the EU, the European Medicines Agency (EMA) keeps... Read more »
